TY - JOUR
T1 - Macrophages induce differentiation of plasma cells through CXCL10/IP-10
AU - Xu, Wei
AU - Joo, HyeMee
AU - Clayton, Sandra
AU - Dullaers, Melissa
AU - Herve, Marie Cecile
AU - Blankenship, Derek
AU - De La Morena, Maria Teresa
AU - Balderas, Robert
AU - Picard, Capucine
AU - Casanova, Jean Laurent
AU - Pascual, Virginia
AU - Oh, SangKon
AU - Banchereau, Jacques
PY - 2012/9
Y1 - 2012/9
N2 - In tonsils, CD138+ plasma cells (PCs) are surrounded by CD163+ resident macrophages (Mφs). We show here that human Mφs (isolated from tonsils or generated from monocytes in vitro) drive activated B cells to differentiate into CD138+CD38++ PCs through secreted CXCL10/IP-10 and VCAM-1 contact. IP-10 production by Mφs is induced by B cell-derived IL-6 and depends on STAT3 phosphorylation. Furthermore, IP-10 amplifies the production of IL-6 by B cells, which sustains the STAT3 signals that lead to PC differentiation. IP-10- deficient mice challenged with NP-Ficoll show a decreased frequency of NP-specific PCs and lower titers of antibodies. Thus, our results reveal a novel dialog between Mφs and B cells, in which IP-10 acts as a PC differentiation factor.
AB - In tonsils, CD138+ plasma cells (PCs) are surrounded by CD163+ resident macrophages (Mφs). We show here that human Mφs (isolated from tonsils or generated from monocytes in vitro) drive activated B cells to differentiate into CD138+CD38++ PCs through secreted CXCL10/IP-10 and VCAM-1 contact. IP-10 production by Mφs is induced by B cell-derived IL-6 and depends on STAT3 phosphorylation. Furthermore, IP-10 amplifies the production of IL-6 by B cells, which sustains the STAT3 signals that lead to PC differentiation. IP-10- deficient mice challenged with NP-Ficoll show a decreased frequency of NP-specific PCs and lower titers of antibodies. Thus, our results reveal a novel dialog between Mφs and B cells, in which IP-10 acts as a PC differentiation factor.
UR - http://www.scopus.com/inward/record.url?scp=84870280096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870280096&partnerID=8YFLogxK
U2 - 10.1084/jem.20112142
DO - 10.1084/jem.20112142
M3 - Article
C2 - 22987802
AN - SCOPUS:84870280096
SN - 0022-1007
VL - 209
SP - 1813
EP - 1823
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 10
ER -